Interferon-β administration confers a beneficial outcome in a rabbit model of thromboembolic cerebral ischemia
- 19 July 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 327 (2) , 146-148
- https://doi.org/10.1016/s0304-3940(02)00371-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interferon α/β Promotes Cell Survival by Activating Nuclear Factor κB through Phosphatidylinositol 3-Kinase and AktJournal of Biological Chemistry, 2001
- Molecular mechanisms of ischemic neuronal injuryAnnals of Emergency Medicine, 2000
- Brain tissue responses to ischemiaJournal of Clinical Investigation, 2000
- Apoptotic and antiapoptotic mechanisms in strokeCell and tissue research, 2000
- Complement depletion does not reduce brain injury in a rabbit model of thromboembolic strokeBrain Research Bulletin, 1999
- Clinical trials in acute strokeNeurology, 1998
- Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectivesJournal of Neuroscience Research, 1998
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993
- Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosisPublished by Elsevier